跳至主要内容
临床试验/NCT02912273
NCT02912273已完成不适用

Optimizing Fall-risk Prediction in Older Adults With Cancer

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 227 人开始时间: 2016年10月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
227
试验地点
1
主要终点
Number of falls

研究概览

简要总结

To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents or hormonal agents (e.g. anti-estrogen or anti-androgen) OR will begin systemic therapy within the next 4 weeks.
  • Estimated life expectancy >1 year
  • Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
  • Able to understand and willing to sign an IRB-approved written informed consent document

排除标准

  • Unable to read and understand English

结局指标

主要结局

Number of falls

时间窗: Up to 6 months

-The Prevention of Falls Network Europe (PROFANE) Consensus Group guidelines will be used

次要结局

  • Overall survival(Up to 6 months)
  • Time to fall event(Up to 6 months)
  • Number of falls that were considered injurious falls(Up to 6 months)
  • Fear of falling as Measured by the Falls Efficacy Scale-International(Up to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验